The 2017 ASCO guidelines present six well-reasoned recommendations for the management of small renal masses. We expand these recommendations to contextualize the use of renal tumour biopsy, clarify when active surveillance could be more inclusive, and highlight nuances in surgical decision making for patients with anatomically complex tumours and a normal contralateral kidney.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Finelli, A. et al. Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2016.69.9645 (2017).
Richard, P. O. et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur. Urol. 68, 1007–1013 (2015).
Kutikov, A. et al. Renal mass biopsy: always, sometimes, or never? Eur. Urol. 70, 403–406 (2016).
Patel, H. D. et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J. Urol. 195, 1340–1347 (2016).
Ristau, B. T., Correa, A. F., Uzzo, R. G. & Smaldone, M. C. Active surveillance for the small renal mass: growth kinetics and oncologic outcomes. Urol. Clin. North. Am. (in press) (2017).
Pierorazio, P. M. et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur. Urol. 68, 408–415 (2015).
Mehrazin, R. et al. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J. Urol. 192, 659–664 (2014).
Kutikov, A. et al. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J. Urol. 188, 2077–2083 (2012).
Lane, B. R. et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur. Urol. 68, 996–1003 (2015).
Smaldone, M. C., Egleston, B., Uzzo, R. G. & Kutikov, A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J. Urol. 188, 2089–2094 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ristau, B., Smaldone, M. Emerging guidelines for managing small renal masses. Nat Rev Urol 14, 329–330 (2017). https://doi.org/10.1038/nrurol.2017.33
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.33
